CollPlant Biotechnologies Ltd. (CLGN)

CollPlant Biotechnologies Statistics

Total Valuation

CLGN has a market cap or net worth of $7.63 million. The enterprise value is $4.88 million.

Market Cap	7.63M
Enterprise Value	4.88M

Important Dates

The last earnings date was Thursday, March 26, 2026, before market open.

Earnings Date	Mar 26, 2026
Ex-Dividend Date	n/a

Share Statistics

CLGN has 14.42 million shares outstanding. The number of shares has increased by 6.54% in one year.

Current Share Class	14.42M
Shares Outstanding	14.42M
Shares Change (YoY)	+6.54%
Shares Change (QoQ)	+0.50%
Owned by Insiders (%)	28.51%
Owned by Institutions (%)	11.00%
Float	10.13M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.22
Forward PS	0.94
PB Ratio	1.11
P/TBV Ratio	1.27
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	2.06
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.53, with a Debt / Equity ratio of 0.47.

Current Ratio	2.53
Quick Ratio	2.18
Debt / Equity	0.47
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -117.56% and return on invested capital (ROIC) is -56.35%.

Return on Equity (ROE)	-117.56%
Return on Assets (ROA)	-48.67%
Return on Invested Capital (ROIC)	-56.35%
Return on Capital Employed (ROCE)	-141.54%
Weighted Average Cost of Capital (WACC)	6.86%
Revenue Per Employee	$41,596
Profits Per Employee	-$201,561
Employee Count	57
Asset Turnover	0.16
Inventory Turnover	1.65

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -79.42% in the last 52 weeks. The beta is 0.94, so CLGN's price volatility has been similar to the market average.

Beta (5Y)	0.94
52-Week Price Change	-79.42%
50-Day Moving Average	0.86
200-Day Moving Average	1.80
Relative Strength Index (RSI)	34.80
Average Volume (20 Days)	32,034

Short Selling Information

The latest short interest is 68,335, so 0.76% of the outstanding shares have been sold short.

Short Interest	68,335
Short Previous Month	75,852
Short % of Shares Out	0.76%
Short % of Float	n/a
Short Ratio (days to cover)	0.95

Income Statement

In the last 12 months, CLGN had revenue of $2.37 million and -$11.49 million in losses. Loss per share was -$0.94.

Revenue	2.37M
Gross Profit	1.54M
Operating Income	-11.48M
Pretax Income	-11.49M
Net Income	-11.49M
EBITDA	-10.57M
EBIT	-11.48M
Loss Per Share	-$0.94

Balance Sheet

The company has $5.59 million in cash and $2.85 million in debt, with a net cash position of $2.75 million or $0.19 per share.

Cash & Cash Equivalents	5.59M
Total Debt	2.85M
Net Cash	2.75M
Net Cash Per Share	$0.19
Equity (Book Value)	6.08M
Book Value Per Share	0.47
Working Capital	4.08M

Cash Flow

In the last 12 months, operating cash flow was -$9.42 million and capital expenditures -$28,000, giving a free cash flow of -$9.45 million.

Operating Cash Flow	-9.42M
Capital Expenditures	-28,000
Depreciation & Amortization	912,000
Net Borrowing	n/a
Free Cash Flow	-9.45M
FCF Per Share	-$0.66

Margins

Gross Margin	64.78%
Operating Margin	-484.31%
Pretax Margin	-484.56%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CLGN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-6.54%
Shareholder Yield	-6.54%
Earnings Yield	-150.66%
FCF Yield	-123.89%

Analyst Forecast

The average price target for CLGN is $11.00, which is 1,979.40% higher than the current price. The consensus rating is "Buy".

Price Target	$11.00
Price Target Difference	1,979.40%
Analyst Consensus	Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on November 21, 2016. It was a reverse split with a ratio of 1:1.5.

Last Split Date	Nov 21, 2016
Split Type	Reverse
Split Ratio	1:1.5

Scores

CLGN has an Altman Z-Score of -15.23 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-15.23
Piotroski F-Score	3